New ESC-EACTS guidelines on myocardial revascularization to be released at EuroPCR 2014
Interventional community presented with preview of 2014 revascularization guidelines
2014-05-20
(Press-News.org) 20 May 2014, Paris, France: EuroPCR 2014 delegates will get a preview of the latest 2014 European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) guidelines on myocardial revascularisation on Wednesday, 21 May at 10.30 am.
The guidelines will be a new version following the first edition in 2010. The new taskforce is chaired by Prof Stephan Windecker, President-elect, European Association for Percutaneous Cardiovascular Interventions (EAPCI), and Prof Philippe Kolh, representing EACTS, who was also co-chair of the previous task force.
The latest update continues to emphasise the importance of the Heart Team approach in treating patients with advanced coronary artery disease (CAD). It also underscores the benefit of coronary artery bypass grafting (CABG) in patients with advanced multivessel coronary artery disease (Syntax Score [SS] >22). Similarly, the new guidelines recommend CABG in diabetic patients with advanced multivessel disease. Conversely, percutaneous coronary intervention (PCI) is recognised as an alternative in patients with proximal left anterior descending artery disease, simple left main lesions and simple three vessel CAD (SS END
ELSE PRESS RELEASES FROM THIS DATE:
Planting the 'SEEDS' of solar technology in the home
2014-05-20
In an effort to better understand what persuades people to buy photovoltaic (PV) systems for their homes, researchers at Sandia National Laboratories are gathering data on consumer motivations that can feed sophisticated computer models and thus lead to greater use of solar energy.
A primary goal of the project is to help increase the nation's share of solar energy in the electricity market from its current share of less than .05 percent to at least 14 percent by 2030. This is the second year of a three-year effort.
"If we can develop effective and accurate predictive ...
E-cigarette use for quitting smoking is associated with improved success rates
2014-05-20
People attempting to quit smoking without professional help are approximately 60% more likely to report succeeding if they use e-cigarettes than if they use willpower alone or over-the-counter nicotine replacement therapies such as patches or gum, finds a large UCL (University College London) survey of smokers in England. (1) The results were adjusted for a wide range of factors that might influence success at quitting, including age, nicotine dependence, previous quit attempts, and whether quitting was gradual or abrupt.
The study, published in Addiction, surveyed 5,863 ...
Prolaris® test predicts mortality risk in prostate cancer biopsy study
2014-05-20
SALT LAKE CITY, Utah, May 20, 2014 – Myriad Genetics, Inc. (NASDAQ: MYGN) today presented new data from a clinical validation study of Prolaris at the 2014 American Urological Association (AUA) Annual Meeting in Orlando, Fla. The study is the largest validation study to date of any gene-based prognostic test in patients with prostate cancer who were diagnosed by needle biopsy. A key finding was that the Prolaris test accurately differentiated newly diagnosed patients who were likely to die from prostate cancer within 10 years from those with lower-risk disease, which ...
Testing a paleo diet hypothesis in the test tube
2014-05-20
By comparing how gut microbes from human vegetarians and grass-grazing baboons digest different diets, researchers have shown that ancestral human diets, so called "paleo" diets, did not necessarily result in better appetite suppression. The study, published in mBio® the online open-access journal of the American Society for Microbiology, reveals surprising relationships between diet and the release of hormones that suppress eating.
While Western diets have changed dramatically in the last century to become high energy, low fiber, and high fat (think: cheeseburger), ...
Global progress in preventing newborn deaths and stillbirths hindered by inadequate investment, leadership, measurement and accountability
2014-05-20
A major new Series of papers, published today [Tuesday 20 May] in The Lancet, presents the clearest picture to date of progress and challenges in improving newborn survival around the world, and sets targets that must be achieved by 2030 in order to ensure every newborn has a healthy start.
The research is led by Professor Joy Lawn, at the London School of Hygiene & Tropical Medicine and Save the Children, UK, with Professor Zulfiqar Bhutta at the Hospital for Sick Children, Canada, and the Aga Khan University, Pakistan, in collaboration with more than 54 experts from ...
New figures on global newborn deaths and stillbirths reveal 5.5 million 'invisible deaths' every year
2014-05-20
A major new Series of papers, published today [Tuesday 20 May] in The Lancet, presents the clearest picture to date of progress and challenges in improving newborn survival around the world, and sets targets that must be achieved by 2030 in order to ensure every newborn has a healthy start.
The research is led by Professor Joy Lawn, at the London School of Hygiene & Tropical Medicine and Save the Children, UK, with Professor Zulfiqar Bhutta at the Hospital for Sick Children, Canada, and the Aga Khan University, Pakistan, in collaboration with more than 54 experts from ...
Analysis reveals triple return on investment to save 3 million mothers' and babies' lives annually
2014-05-20
A major new Series of papers, published today [Tuesday 20 May] in The Lancet, presents the clearest picture to date of progress and challenges in improving newborn survival around the world, and sets targets that must be achieved by 2030 in order to ensure every newborn has a healthy start.
The research is led by Professor Joy Lawn, at the London School of Hygiene & Tropical Medicine and Save the Children, UK, with Professor Zulfiqar Bhutta at the Hospital for Sick Children, Canada, and the Aga Khan University, Pakistan, in collaboration with more than 54 experts from ...
First ever consultation of countries with highest newborn death rates underlines urgent need for more investment, medicines, and health workers
2014-05-20
A major new Series of papers, published today [Tuesday 20 May] in The Lancet, presents the clearest picture to date of progress and challenges in improving newborn survival around the world, and sets targets that must be achieved by 2030 in order to ensure every newborn has a healthy start.
The research is led by Professor Joy Lawn, at the London School of Hygiene & Tropical Medicine and Save the Children, UK, with Professor Zulfiqar Bhutta at the Hospital for Sick Children, Canada, and the Aga Khan University, Pakistan, in collaboration with more than 54 experts from ...
Action plan will provide blueprint for progress, but preventable newborn deaths will be eliminated only with political commitment
2014-05-20
A major new Series of papers, published today [Tuesday 20 May] in The Lancet, presents the clearest picture to date of progress and challenges in improving newborn survival around the world, and sets targets that must be achieved by 2030 in order to ensure every newborn has a healthy start.
The research is led by Professor Joy Lawn, at the London School of Hygiene & Tropical Medicine and Save the Children, UK, with Professor Zulfiqar Bhutta at the Hospital for Sick Children, Canada, and the Aga Khan University, Pakistan, in collaboration with more than 54 experts from ...
A call to arms in cancer research
2014-05-19
SAN ANTONIO (May 19, 2014) — Hispanics are the fastest-growing demographic group in the United States, and they suffer from major health disparities, including higher rates of cancers of the cervix, stomach and liver.
However, their enrollment levels in cancer clinical trials seeking to cure these problems is abysmally low: 3.9 percent.
In a paper published today in the Journal of Clinical Oncology, three physicians from The University of Texas Health Science Center at San Antonio analyzed Hispanic accrual rates to randomized clinical trials, and in response to the ...
LAST 30 PRESS RELEASES:
Gut microbiome influences proteins that drive aging and disease
NIH funds first-of-its-kind center to study resilience and aging
Mesonephric carcinoma and mesonephric-like adenocarcinoma of the female genital tract
Rural patients in the United States still face barriers to telehealth access
Emphysema at CT lung screening increases death risk in asymptomatic adults
Brain iron on MRI predicts cognitive impairment, decline
The ISSCR partners with Nuffield Council on Bioethics to compile global horizon scan on stem cell research
Machine learning unveils COPD patient clusters and quality of life associations in China
No sign of toxic effects of inhaled anesthesia in young children
CUNY SPH expands curriculum with concentration in sexual and reproductive justice and health
High consumption of ultra-processed foods linked to systemic inflammation
City of Hope launches transformative national clinical trials model to accelerate cancer research
Inside an academic scandal: a story of fraud and betrayal
Innovative ultrasonic regeneration restores nano-phase change emulsions for low-temperature applications
Targeted snow monitoring at hotspots outperforms basin-wide surveys in predicting water supply
Decades-old barrels of industrial waste still impacting ocean floor off Los Angeles
Finalists announced for the 2025 Blavatnik National Awards for Young Scientists
Alkali waste dumped in the Pacific Ocean created alkalophilic ecosystems
Bacterial ink to restore coral reefs
AI-based satellite count of migrating wildebeest
Bee-sting inspired microneedles from Chung-Ang University could revolutionize drug delivery
Pusan National University researchers reveal how uneven ocean warming is altering propagation of the Madden-Julian oscillation
Mapping causality in neuronal activity: towards a better understanding of brain networks
New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer
Scientists find curvy answer to harnessing “swarm intelligence”
PALOMA-2 study: Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC
First 3D real-time imaging of hydrogen’s effect on stainless steel defects opens the way to a safer hydrogen economy
Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows
Novel immunotherapy strategy shows promising long-term survival in advanced NSCLC patients with inadequate response to immune checkpoint inhibitors
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
[Press-News.org] New ESC-EACTS guidelines on myocardial revascularization to be released at EuroPCR 2014Interventional community presented with preview of 2014 revascularization guidelines